WALL FINANCIAL CORPORATION ANNOUNCES Q4 2025 FISCAL RESULTS

Xenon to Report Q1 2025 Financial Results on May 12, 2025

VANCOUVER, British Columbia and BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced it will report its first quarter…

WALL FINANCIAL CORPORATION ANNOUNCES Q4 2025 FISCAL RESULTS

VANCOUVER, BC, May 5, 2025 /CNW/ - Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year ended January 31, 2025. The Company recorded net earnings and comprehensive income attributable to shareholders of the Company for the year ended January 31, 2025 of $27,405,502 or $0.85 per share compared to $22,233,339 or $0.69 per share in the prior year. Revenue and income from t…